Abstract
Human and mouse genetic studies have led to significant advances in our understanding of the role of voltage-gated sodium channels in pain pathways. In this chapter, we focus on Nav1.7, Nav1.8, Nav1.9 and Nav1.3 and describe the insights gained from the detailed analyses of global and conditional transgenic Nav knockout mice in terms of pain behaviour. The spectrum of human disorders caused by mutations in these channels is also outlined, concluding with a summary of recent progress in the development of selective Nav1.7 inhibitors for the treatment of pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrahamsen B, Zhao J et al (2008) The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 321(5889):702–705
Akopian AN, Sivilotti L et al (1996) A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379(6562):257–262
Akopian AN, Souslova V et al (1999) The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2(6):541–548
Amaya F, Wang H et al (2006) The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci 26(50):12852–12860
Baker MD, Chandra SY et al (2003) GTP-induced tetrodotoxin-resistant Na+ current regulates excitability in mouse and rat small diameter sensory neurones. J Physiol 548(Pt 2):373–382
Beckh S, Noda M et al (1989) Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. EMBO J 8(12):3611–3616
Black JA, Frezel N et al (2012) Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol Pain 8:82
Catterall WA (2014) 2013 Sharpey-Schafer Prize Lecture: structure and function of voltage-gated sodium channels at atomic resolution. Exp Physiol 99(1):35–51
Cox JJ, Reimann F et al (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444(7121):894–898
Cox JJ, Sheynin J et al (2010) Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum Mutat 31(9):E1670–E1686
Cummins TR, Waxman SG (1997) Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 17(10):3503–3514
Cummins TR, Howe JR et al (1998) Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 18(23):9607–9619
Cummins TR, Dib-Hajj SD et al (1999) A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci 19(24):RC43
Cummins TR, Dib-Hajj SD et al (2004) Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 24(38):8232–8236
Dib-Hajj SD, Tyrrell L et al (1998) NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci U S A 95(15):8963–8968
Dib-Hajj SD, Fjell J et al (1999) Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 83(3):591–600
Dib-Hajj S, Black JA et al (2002) NaN/Nav1.9: a sodium channel with unique properties. Trends Neurosci 25(5):253–259
Dib-Hajj SD, Cummins TR et al (2010) Sodium channels in normal and pathological pain. Annu Rev Neurosci 33:325–347
Eijkelkamp N, Linley JE et al (2012) Neurological perspectives on voltage-gated sodium channels. Brain 135(Pt 9):2585–2612
Estacion M, Dib-Hajj SD et al (2008) NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 28(43):11079–11088
Faber CG, Hoeijmakers JG et al (2012a) Gain of function Nanu1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71(1):26–39
Faber CG, Lauria G et al (2012b) Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A 109(47):19444–19449
Fang X, Djouhri L et al (2002) The presence and role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons. J Neurosci 22(17):7425–7433
Fertleman CR, Baker MD et al (2006) SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52(5):767–774
Goldberg YP, MacFarlane J et al (2007) Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 71(4):311–319
Goldberg Y, Pimstone S et al (2012a) Human Mendelian pain disorders: a key to discovery and validation of novel analgesics. Clin Genet 82(4):367–373
Goldberg YP, Price N et al (2012b) Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker. Pain 153(1):80–85
Goldin AL, Barchi RL et al (2000) Nomenclature of voltage-gated sodium channels. Neuron 28(2):365–368
Hayden R, Grossman M (1959) Rectal, ocular, and submaxillary pain; a familial autonomic disorder related to proctalgia fugaz: report of a family. AMA J Dis Child 97(4):479–482
Herzog RI, Cummins TR et al (2001) Persistent TTX-resistant Na+ current affects resting potential and response to depolarization in simulated spinal sensory neurons. J Neurophysiol 86(3):1351–1364
Herzog RI, Cummins TR et al (2003) Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons. J Physiol 551(Pt 3):741–750
Huang J, Yang Y et al (2013) Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons. J Neurosci 33(35):14087–14097
Kerr BJ, Souslova V et al (2001) A role for the TTX-resistant sodium channel Nav 1.8 in NGF-induced hyperalgesia, but not neuropathic pain. Neuroreport 12(14):3077–3080
Klugbauer N, Lacinova L et al (1995) Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 14(6):1084–1090
Kremeyer B, Lopera F et al (2010) A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron 66(5):671–680
Leipold E, Liebmann L et al (2013) A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet 45(11):1399–1404
Leo S, D’Hooge R et al (2010) Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice. Behav Brain Res 208(1):149–157
Lolignier S, Amsalem M et al (2011) Nav1.9 channel contributes to mechanical and heat pain hypersensitivity induced by subacute and chronic inflammation. PLoS One 6(8):e23083
McCormack K, Santos S et al (2013) Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels. Proc Natl Acad Sci U S A 110(29):E2724–E2732
Middleton RE, Warren VA et al (2002) Two tarantula peptides inhibit activation of multiple sodium channels. Biochemistry 41(50):14734–14747
Minett MS, Quick K, Wood JN (2011) Behavioral measures of pain thresholds. In: Auwerx J, Brown SD, Justice M, Moore DD, Ackerman SL, Nadeau J (eds) Current protocols in mouse biology. Wiley, Hoboken
Minett MS, Nassar MA et al (2012) Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun 3:791
Nassar MA, Stirling LC et al (2004) Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A 101(34):12706–12711
Nassar MA, Levato A et al (2005) Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol Pain 1:24
Nassar MA, Baker MD et al (2006) Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol Pain 2:33
Patino GA, Isom LL (2010) Electrophysiology and beyond: multiple roles of Na+ channel beta subunits in development and disease. Neurosci Lett 486(2):53–59
Priest BT, Murphy BA et al (2005) Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci U S A 102(26):9382–9387
Priest BT, Blumenthal KM et al (2007) ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels. Toxicon 49(2):194–201
Ragsdale DS, McPhee JC et al (1994) Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science 265(5179):1724–1728
Ragsdale DS, McPhee JC et al (1996) Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci U S A 93(17):9270–9275
Reed KB, Davis MD (2009) Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota. J Eur Acad Dermatol Venereol 23(1):13–15
Renganathan M, Cummins TR et al (2001) Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 86(2):629–640
Rotthier A, Baets J et al (2012) Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol 8(2):73–85
Schmalhofer WA, Calhoun J et al (2008) ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors. Mol Pharmacol 74(5):1476–1484
Theile JW, Cummins TR (2011) Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. Front Pharmacol 2:54
Toledo-Aral JJ, Moss BL et al (1997) Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci U S A 94(4):1527–1532
Waxman SG, Kocsis JD et al (1994) Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 72(1):466–470
Weiss J, Pyrski M et al (2011) Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature 472(7342):186–190
Whitaker WR, Faull RL et al (2001) Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res Mol Brain Res 88(1–2):37–53
Yang Y, Wang Y et al (2004) Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 41(3):171–174
Yang S, Xiao Y et al (2013) Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models. Proc Natl Acad Sci U S A 110(43):17534–17539
Yuan J, Matsuura E et al (2013) Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation. Neurology 80(18):1641–1649
Zhang XY, Wen J et al (2013) Gain-of-function mutations in SCN11A cause familial episodic pain. Am J Hum Genet 93(5):957–966
Zimmermann K, Leffler A et al (2007) Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures. Nature 447(7146):855–858
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Habib, A.M., Wood, J.N., Cox, J.J. (2015). Sodium Channels and Pain. In: Schaible, HG. (eds) Pain Control. Handbook of Experimental Pharmacology, vol 227. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46450-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-46450-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46449-6
Online ISBN: 978-3-662-46450-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)